Search Result "MIL"
Cyclophosphamide Loading and Controlled Release in MIL-100(Fe) as anAnti-breast Cancer Carrier: In vivo In vitro Study
Journal: Current Drug Delivery
Volume: 21 Issue: 2 Year: 2024 Page: 283-294
Author(s):
MIL-101(Cr) MOF as a Support for Reactive Polyoxometalates (POMs) Clusters. Principles of POMs Encapsulation and Chemistry of POMs Inside MIL-101 Cavities
Journal: Current Inorganic Chemistry (Discontinued)
Volume: 7 Issue: 2 Year: 2017 Page: 145-156
Author(s): Romain Canioni,Catherine Roch-Marchal,Mohamed Haouas,Alexandre Vimont,Patricia Horcajada,Francis Secheresse,Christian Serre
Effect of Chitosan Coating on Drug Carrier Capacity of Metal-organicFramework MIL-100(Fe) Contained Cyclophosphamide
Journal: Current Medicinal Chemistry
Volume: 32 Issue: 18 Year: 2025 Page: 3719-3733
Author(s):
MIL-101(Cr)-Functionalized TEDA-BAIL: An Efficient and RecyclableCatalyst for the Synthesis of Pyrimido[4,5-b]quinolinetrione Derivatives
Journal: Current Organocatalysis
Volume: 10 Issue: 1 Year: 2023 Page: 3-18
Author(s): Mohammad Ali Ghasemzadeh
Benign Synthesis of Metal-organic Framework (MIL-101-Cr) and Evaluation of Carbon-dioxide Adsorption Behaviour Employing Adsorption Isotherm Models
Journal: Current Organic Synthesis
Volume: 19 Issue: 5 Year: 2022 Page: 673-684
Author(s):
Recent Advances in Fe-MOF Compositions for Biomedical Applications
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 30 Year: 2021 Page: 6179-6198
Author(s): Yuyu Zhong,Weicong Liu,Congying Rao,Baohong Li,Xiaoxiong Wang,Dong Liu,Ying Pan,Jianqiang Liu
Metal-based Ionic Liquids and Solid-loaded Catalysts in Fuel Oil Desulfurization:A Review
Journal: Mini-Reviews in Organic Chemistry
Volume: 21 Issue: 7 Year: 2024 Page: 704-716
Author(s):
Levamisole-Induced Leukoencephalopathy in Russia: Analysis of 30 Cases
Journal: Current Drug Safety
Volume: 17 Issue: 4 Year: 2022 Page: 319-326
Author(s):
Cytotoxicity Effects of Miltefosine and Niosomal form on Human UmbilicalVein Endothelial Cells: Colorimetric Assay, Apoptosis, and Gene ExpressionProfiling
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 12 Year: 2023 Page: 1936-1946
Author(s):
Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 6 Year: 2018 Page: 577-591
Author(s): Tiantian Zhang,Dennis H. Kordish,Yogesh R. Suryawanshi,Rob R. Eversole,Steven Kohler,Charles D. Mackenzie,Karim Essani